《抗癌药》(Anti-cancer Drugs)是一本以医学-药学综合研究为特色的国际期刊。该刊由Lippincott Williams and Wilkins Ltd.出版商创刊于1990年,刊期Monthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-药学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信息窗...
期刊名称Anti-Cancer Drugs ANTI-CANCER DRUG 期刊ISSN0959-4973 期刊官方网站https://journals.lww.com/anti-cancerdrugs/pages/default.aspx 是否OANo 出版商Lippincott Williams and Wilkins Ltd. 出版周期Monthly 文章处理费登录后查看 始发年份1990 年文章数142 ...
Anti-cancer Drugs创刊于1990年,由Lippincott Williams and Wilkins Ltd.出版商出版,收稿方向涵盖医学 - 药学全领域,此期刊水平偏中等偏靠后,在所属细分领域中专业影响力一般,过审相对较易,如果您文章质量佳,选择此期刊,发表机率较高。平均审稿速度 偏慢,4-8周 ,影响因子指数1.8,该期刊近期没有被列入国际期刊预...
Posted inCANCER BIOLOGY & Innovations in Cancer Therapy,Cancer Prevention: Research & Programs,Clinical & Translational,Disease Biology, Small Molecules in Development of Therapeutic Drugs,FDA Regulatory Affairs,Health Economics and Outcomes Research,Pharmaceutical Discovery,Pharmaceutical Drug Discovery,Pharmaceut...
ANTI-CANCER DRUGSISSN:0959-4973 E-ISSN:1473-5741 分区:中科院4区;JCR:Q4 影响因子:2.248 检索类型:Article 检索情况:SCI检索 语种:英语 审稿周期:约3个月左右 出版商:Lippincott Williams and Wilki…
Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast ...
nature nature communications articles article Article Open access Published: 29 March 2019 The anti-cancer drugs curaxins target spatial genome organization Omar L. Kantidze, Artem V. Luzhin, Ekaterina V. Nizovtseva, Alfiya Safina, Maria E. Valieva, Arkadiy K. Golov, Artem K. ...
Anti-Cancer Drugs报告与抗癌药物相关的临床和实验结果,并欢迎抗癌药物设计、药物递送、药理学、激素和生物模式以及化疗评估方面做出贡献。致力于快速发表关于抗癌药物、 抗癌药物的创新研究旨在刺激和报告对有毒和无毒抗癌剂的研究。该期刊的范围将涵盖传统的细胞毒性化学疗法和激素或生...
CANCER cell growthCHEMOKINE receptorsPROGNOSISBOTANICAL chemistryThis document is a summary of various studies and review articles related to cancer treatment. The studies explore the potential of different compounds and natural products in treating various types of cancer. The findings suggest ...
Cancer Drugs that were published more than 3 months prior. Correspondence concerning articles that have not been published in Anti-Cancer Drugs will not be considered. The length restrictions are as follows: 400 words of text, 5 references, the first of which must be the citation for the ...